EFFECTIVENESS AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB FORMULATION IN INFLAMMATORY BOWEL DISEASE PATIENTS IN CLINICAL REMISSION
Laura Parisio 1
Carlo Romano Settanni 1
Daniele Napolitano 1
Simone Varca 1
Elisa Schiavoni 1
Lucrezia Laterza 1
Loris Riccardo Lopetuso 2
Marco Pizzoferrato
Stefano Bibbò
Norma Alfieri
Luisa Guidi
Alfredo Papa
Antonio Gasbarrini
Alessandro Armuzzi
Daniela Pugliese
Franco Scaldaferri
1 Fondazione Policlinico Gemelli, IRCCS, Rome, Italy
2 University of Chieti-Pe
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing